PRIMA cohort reports low 30-day hospitalization or death among high-risk Italian outpatients treated early with nirmatrelvir/ritonavir
A 15-center Italian retrospective cohort found 30-day hospitalization or death in 0.9% of 3,916 high-risk outpatients treated early with nirmatrelvir/ritonavir, ...
